Angiolite Registry Study for heart artery stents
Part of Heart & circulation clinical trials.
This study is testing a new type of stent for people with a blockage in the main artery of the heart. It aims to see how well the stent works and if it's safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a blockage in the main artery of your heart (left main coronary artery) that needs a stent.
- The blockage is more than 50% but not completely blocked, and the artery is between 2.0 and 6.0 mm wide.
- You are not allergic to sirolimus (a common medicine on stents) or fluoroacrylate (a medical glue).
- You are not pregnant or breastfeeding, and you are not in another device study that hasn't finished yet.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new stent (a small mesh tube) to open narrowed heart arteries and improve blood flow. It may help people with multiple blocked arteries who are having a procedure to widen them.
This study looks at patients who received a special type of heart stent (a small mesh tube that holds open a blocked artery) during a procedure called angioplasty at Geneva University Hospitals. The goal is to see how safe and effective this stent is in everyday practice.
This trial studies a new way to treat blockages in the left main coronary artery using a drug-coated stent. It aims to find out if a careful approach with a single stent and temporary side-branch support works well for people with heart disease.
This study compares two types of devices used to open blocked heart arteries during a heart attack or unstable chest pain: one is a scaffold made of magnesium that dissolves over time, the other is a permanent stent with a coating that releases medicine. The goal is to see which device works better for patients like you.
This study tests whether using a drug-coated balloon alongside a stent improves outcomes for people with a blockage in the left main coronary artery, the main artery supplying the heart. It compares this approach to standard stenting, aiming to reduce re-blockage risk.
This trial is testing a new type of stent (a small tube that props open a narrowed heart artery) coated with a medicine called everolimus to keep the artery open. The study wants to see if the stent is safe and works well for people with coronary artery disease, which is narrowing of the heart's blood vessels.
Hear when a new With Left Main Coronary Artery Lesions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.